Mark S. Cooper

10.1k citations

135 papers · 7.2k indexed · 2 hit papers · h-index 42

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Adrenal Hormones and Disorders
- Hormonal Regulation and Hypertension
- Pituitary Gland Disorders and Treatments
Behavioral Neuroscience top 1%
- Stress Responses and Cortisol

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 77
- Adrenal Hormones and Disorders 64
- Hormonal Regulation and Hypertension 53
- Pituitary Gland Disorders and Treatments 10
Behavioral Neuroscience 10
- Stress Responses and Cortisol 10

Co-authors: Paul M. Stewart (34 shared papers)Rowan Hardy (29 shared papers)Martin Hewison (16 shared papers)Markus J. Seibel (14 shared papers)Elizabeth A. Walker (6 shared papers)Gareth G. Lavery (17 shared papers)Jeremy Tomlinson (6 shared papers)Iwona Bujalska (5 shared papers)
Journals: Arthritis Research & Therapy (7 papers)The Journal of Clinical Endocrinology & Metabolism (4 papers)Annals of the Rheumatic Diseases (4 papers)Journal of Endocrinology (4 papers)Endocrine Reviews (3 papers)
Partner nations: United Kingdom Australia United States

In The Last Decade

Mark S. Cooper

131 papers receiving 7.0k citations

Hit Papers

align trajectories log scale

11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response 2004 · 801 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2004 Endocrine Reviews
2003 New England Journal of Medicine

Peers

Countries citing papers authored by Mark S. Cooper

Since Specialization

Citations

This map shows the geographic impact of Mark S. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Cooper more than expected).

Fields of papers citing papers by Mark S. Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Cooper. The network helps show where Mark S. Cooper may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark S. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark S. Cooper Line = papers co-authored together Mark S. Cooper links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response Endocrine Reviews ·Jeremy Tomlinson, Elizabeth A. Walker, Iwona Bujalska, Nicole L. Draper, Gareth G. Lavery, Mark S. Cooper, Martin Hewison, Paul M. Stewart Hit paper breakdown →	2004	801
2	Corticosteroid Insufficiency in Acutely Ill Patients New England Journal of Medicine ·Mark S. Cooper, Paul M. Stewart Hit paper breakdown →	2003	706
3	Bone loss in inflammatory disorders Journal of Endocrinology ·Rowan Hardy, Mark S. Cooper	2009	296
4	Diagnosis and management of hypocalcaemia BMJ ·Mark S. Cooper, Neil Gittoes	2008	225
5	Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 Intensive Care Medicine ·Djillali Annane, Stephen M. Pastores, Bram Rochwerg, Wiebke Arlt, R.A. Balk, Albertus Beishuizen, Josef Briegel, Joseph A. Carcillo, Mirjam Christ‐Crain, Mark S. Cooper, Paul E. Marik, G. Umberto Meduri, Keith M. Olsen, Sophia C. Rodgers, James A. Russell, Greet Van den Berghe	2017	219
6	Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 Critical Care Medicine ·Djillali Annane, Stephen M. Pastores, Bram Rochwerg, Wiebke Arlt, R.A. Balk, Albertus Beishuizen, Josef Briegel, Joseph A. Carcillo, Mirjam Christ‐Crain, Mark S. Cooper, Paul E. Marik, G. Umberto Meduri, Keith M. Olsen, Sophia C. Rodgers, James A. Russell, Greet Van den Berghe	2017	215
7	Tubulovesicular processes emerge from trans-Golgi cisternae, extend along microtubules, and interlink adjacent trans-Golgi elements into a reticulum Cell ·Mark S. Cooper, Ann Cornell-Bell, Alex Chernjavsky, John W. Dani, Stephen J Smith	1990	196
8	Regulation of Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue: Tissue-Specific Induction by Cytokines* Endocrinology ·Jeremy Tomlinson, J. Moore, Mark S. Cooper, Iwona Bujalska, Maryam Shahmanesh, Christopher D. B. Burt, Alastair J. Strain, Martin Hewison, Paul M. Stewart	2001	190
9	Modulation of 11β-Hydroxysteroid Dehydrogenase Isozymes by Proinflammatory Cytokines in Osteoblasts: An Autocrine Switch from Glucocorticoid Inactivation to Activation Journal of Bone and Mineral Research ·Mark S. Cooper, Iwona Bujalska, Elizabeth Rabbitt, Elizabeth A. Walker, Rosemary Bland, Michael C. Sheppard, Martin Hewison, Paul M. Stewart	2001	183
10	Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy Endocrine Reviews ·Rowan Hardy, Hong Zhou, Markus J. Seibel, Mark S. Cooper	2018	179
11	Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases Nature Reviews Rheumatology ·Rowan Hardy, Karim Raza, Mark S. Cooper	2020	163
12	Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives The Lancet Diabetes & Endocrinology ·Markus J. Seibel, Mark S. Cooper, Hong Zhou	2013	157
13	Osteoblastic 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Increases With Age and Glucocorticoid Exposure Journal of Bone and Mineral Research ·Mark S. Cooper, Elizabeth Rabbitt, Philippa E. Goddard, William A. Bartlett, Martin Hewison, Paul M. Stewart	2002	157
14	11β-Hydroxysteroid Dehydrogenase 1: Translational and Therapeutic Aspects Endocrine Reviews ·Laura Gathercole, Gareth G. Lavery, Stuart Morgan, Mark S. Cooper, Alexandra J. Sinclair, Jeremy Tomlinson, Paul M. Stewart	2013	145
15	The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease Kidney International ·Kevin S. Eardley, Chandrashekhar A. Kubal, Daniel Zehnder, Marcus Quinkler, Julia Lepenies, Caroline O. S. Savage, A. J. Howie, Kirrenjit Kaur, Mark S. Cooper, Dwomoa Adu, Paul Cockwell	2008	135
16	11β-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation The Journal of Clinical Endocrinology & Metabolism ·Mark S. Cooper, Paul M. Stewart	2009	135
17	Outcome of Cushing's Disease following Transsphenoidal Surgery in a Single Center over 20 Years The Journal of Clinical Endocrinology & Metabolism ·Zaki Hassan‐Smith, Mark Sherlock, Raoul C. Reulen, Wiebke Arlt, John Ayuk, Andrew Toogood, Mark S. Cooper, Alan P. Johnson, Paul M. Stewart	2012	126
18	Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone Bone ·Mark S. Cooper, Elizabeth A. Walker, Rosemary Bland, W.D. Fraser, Martin Hewison, Paul M. Stewart	2000	126
19	Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM) Intensive Care Medicine ·Djillali Annane, Stephen M. Pastores, Wiebke Arlt, R.A. Balk, Albertus Beishuizen, Josef Briegel, Joseph A. Carcillo, Mirjam Christ‐Crain, Mark S. Cooper, Paul E. Marik, G. Umberto Meduri, Keith M. Olsen, Bram Rochwerg, Sophia C. Rodgers, James A. Russell, Greet Van den Berghe	2017	126
20	11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects Journal of Clinical Investigation ·Ana Tiganescu, Abd A. Tahrani, Stuart Morgan, Marcela Otranto, Alexis Desmoulière, Lianne Abrahams, Zaki Hassan‐Smith, Elizabeth A. Walker, Elizabeth Rabbitt, Mark S. Cooper, Kurt E. Amrein, Gareth G. Lavery, Paul M. Stewart	2013	98

About Mark S. Cooper

Mark S. Cooper is a scholar working on Endocrinology, Diabetes and Metabolism, Behavioral Neuroscience, Orthopedics and Sports Medicine, Pharmacology and Rehabilitation, having authored 135 papers that have together received 7.2k indexed citations. Recurring topics across this work include Adrenal Hormones and Disorders (64 papers), Hormonal Regulation and Hypertension (53 papers), Bone health and osteoporosis research (15 papers), Estrogen and related hormone effects (15 papers), Pharmacological Effects of Natural Compounds (11 papers), Pituitary Gland Disorders and Treatments (10 papers), Stress Responses and Cortisol (10 papers) and Bone Metabolism and Diseases (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.5k citations), Behavioral Neuroscience (523 citations), Orthopedics and Sports Medicine (715 citations), Critical Care and Intensive Care Medicine (356 citations) and Pharmacology (406 citations). Mark S. Cooper has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Paul M. Stewart, Rowan Hardy, Martin Hewison, Markus J. Seibel, Elizabeth A. Walker, Gareth G. Lavery, Jeremy Tomlinson, Iwona Bujalska, Hong Zhou and Neil Gittoes. Their work appears in journals such as Arthritis Research & Therapy, The Journal of Clinical Endocrinology & Metabolism, Annals of the Rheumatic Diseases, Journal of Endocrinology and Endocrine Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact